<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="111043">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02026765</url>
  </required_header>
  <id_info>
    <org_study_id>5AT-6M</org_study_id>
    <nct_id>NCT02026765</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes About Heparin Surface Modified Aspheric Lens</brief_title>
  <official_title>Clinical Outcomes About Heparin Surface Modified Aspheric Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to obverse the effect of this type lens in the same as
      traditional aspheric intraocular lens at the same time, whether can further improve the
      effects of operation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Heparin surface treatment lens can reduce inflammatory reaction.

        2. Modified aspheric lens are more in line with human optical properties than the
           traditional aspheric lens.

        3. To obverse the effect of this type lens in the same as traditional aspheric intraocular
           lens at the same time, whether can further improve the effects of operation.

        4. After one day, one week, one month, three month follow-up，Key observation on the flare,
           the optical quality, contrast sensitivity and other parameters.Study the postoperative
           inflammatory reaction with test group lens，and the impact on the visual quality.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>flare value in the anterior chamber after surgery</measure>
    <time_frame>six months</time_frame>
    <safety_issue>No</safety_issue>
    <description>use Laser Flare Meter to measure the flare in the anterior chamber to evaluate postoperative ocular inflammatory reaction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the ocular and the anterior corneal aberration after surgery</measure>
    <time_frame>six months</time_frame>
    <safety_issue>No</safety_issue>
    <description>use wavefront aberrometer to measure the ocular and the anterior corneal aberration to evaluate postoperative ocular optical quality</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Inflammatory Reaction</condition>
  <arm_group>
    <arm_group_label>Heparin Surface Modified Aspheric Lens</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Heparin Surface Modified Aspheric Lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>traditional lens</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>traditional Aspheric lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>traditional lens</intervention_name>
    <description>A random eyes with traditional lens</description>
    <arm_group_label>traditional lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>heparin surface modified aspheric lens</intervention_name>
    <description>the other eye implant heparin surface modified aspheric lens</description>
    <arm_group_label>Heparin Surface Modified Aspheric Lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cataract patients

        Exclusion Criteria:

          -  Eyed patients
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Affiliated Eye hospital of Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xiangxiang zhang, postgraduate</last_name>
      <phone>+8613958809521</phone>
      <email>shoufzhang@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>January 1, 2014</lastchanged_date>
  <firstreceived_date>December 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>A-Yong Yu</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
